SCHEMBL24309386

SCHEMBL24309386

Cc1ccccc1-c1nc(NSc2cnn(C)c2)nc(Oc2ccc(N3CCN(C)CC3)cc2)c1C#N

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 1/20 0.37
▸ JAK1 P23458 1/20 0.37
▸ TYK2 P29597 1/20 0.37
▸ STAT3 P40763 1/20 0.37
▸ JAK3 P52333 1/20 0.37
▸ MAP4K1 Q92918 2/20 0.36
▸ PDE2A O00408 1/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ CDK2 P24941 4/20 0.34
▸ CCNA2 P20248 3/20 0.34
▸ CDK1 P06493 2/20 0.34
▸ CCNB1 P14635 2/20 0.34
▸ CDK7 P50613 2/20 0.34
▸ CCNH P51946 2/20 0.34
▸ CDK4 P11802 1/20 0.34
▸ CCND1 P24385 1/20 0.34
▸ ITK Q08881 1/20 0.34
▸ IGF1R P08069 1/20 0.33
▸ CSF1R P07333 1/20 0.33
▸ TTK P33981 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24310715 0.92 CSF1R (0.35) JAK2JAK1TYK2STAT3JAK3
SCHEMBL24310424 0.88 PDE2A (0.41) JAK2JAK3MAP4K1PDE2APDE10A
SCHEMBL24310428 0.88 MAP4K1 (0.38) JAK2JAK1TYK2STAT3JAK3
SCHEMBL24309869 0.88 CHEK1 (0.33) MAP4K1IGF1RCYP1A2CYP2C19
SCHEMBL24310158 0.87 MAP4K1 (0.37) JAK2JAK1TYK2STAT3JAK3
SCHEMBL24309882 0.87 MAP4K1 (0.37) JAK2JAK1TYK2STAT3JAK3
SCHEMBL24309719 0.87 MAP4K1 (0.37) JAK2JAK1TYK2STAT3JAK3
SCHEMBL24310171 0.86 CTSC (0.36) JAK2JAK1TYK2STAT3JAK3
SCHEMBL24309392 0.85 BRD4 (0.37) JAK2JAK1TYK2STAT3JAK3
SCHEMBL24310417 0.85 LMNA (0.33) IGF1RCYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback